Human Immunodeficiency Virus Types 1 and 2 (HIV-1/2) Antibody Differentiation, Supplemental, With Reflex to HIV-1/HIV-2 by Qualitative NAAT
Also known as: HIV AB DIF
Use
Useful as a supplemental assay for repeatedly reactive third- or fourth-generation HIV screen tests when following the CDC's recommended HIV testing algorithm. This test discriminates between HIV-1 and HIV-2 antibodies and reports results for each type. It should not be used as a rapid screen or as a follow-up test for a positive rapid screen, nor for blood donor screening or HCT/P screening.
Special Instructions
This test is only for use when a patient has a repeatedly reactive third- or fourth-generation HIV screen test result. It is a part of a multitest algorithm recommended by the CDC and CLSI for HIV diagnosis. Additional charges apply if a reflex to the HIV-1/HIV-2 by Qualitative NAAT test is needed.
Limitations
Not suitable for blood donor screening, associated reentry protocols, or HCT/P screening. This test is not to be ordered as a rapid screen test. Negative or indeterminate results in the antibody differentiation immunoassay may trigger reflex testing by NAAT.
Methodology
PCR-based
Biomarkers
LOINC Codes
- 77202-0
- 29893-5
- 30361-0
- 80203-3
Result Turnaround Time
1-2 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
3 mL
Minimum Volume
1.5 mL
Container
ARUP standard transport tube
Collection Instructions
Separate from cells within 24 hours of collection. Transfer 3 mL serum or plasma into an ARUP standard transport tube dedicated only for the HIV AB DIF assay. Remove particulate material. SHIP FROZEN.
Causes for Rejection
Heparinized or citrated plasma specimens. Specimens containing particulate material. Severely hemolyzed or heat-inactivated specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 24 hours |
| Refrigerated | 5 days |
| Frozen | 6 weeks (avoid repeated freeze/thaw cycles) |
Other tests from different labs that may be relevant
